BioNexus Gene Lab Corp. Repayments of Debt
BioNexus Gene Lab Corp. (BGLC) reported Repayments of Debt of -$7.90 thousand for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2020-05-08
- BioNexus Gene Lab Corp. repayments of debt for the quarter ending 2020-03-31 was -$7.90K.
- BioNexus Gene Lab Corp. repayments of debt for the quarter ending 2019-12-31 was -$3.32K.
- BioNexus Gene Lab Corp. repayments of debt for the quarter ending 2019-09-30 was -$21.37K.
- BioNexus Gene Lab Corp. repayments of debt for the quarter ending 2019-06-30 was $11.53K.
- BioNexus Gene Lab Corp. repayments of debt for fiscal 2019 was -$16.78K.
| Period end | Repayments of Debt 3 month | Repayments of Debt 6 month | Repayments of Debt 9 month | Repayments of Debt 12 month |
|---|---|---|---|---|
| 2020-03-31 | -$7.90K 10-Q · filed 2020-05-08 | -$11.22K derived: sum of 2 quarters · filed 2020-05-08 | -$32.60K derived: sum of 3 quarters · filed 2020-05-08 | -$21.07K derived: sum of 4 quarters · filed 2020-05-08 |
| 2019-12-31 | -$3.32K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-31 | -$24.70K derived: sum of 2 quarters · filed 2020-03-31 | -$13.17K derived: sum of 3 quarters · filed 2020-03-31 | -$16.78K 10-K · filed 2020-03-31 |
| 2019-09-30 | -$21.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$9.85K derived: sum of 2 quarters · filed 2019-11-14 | -$13.45K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $11.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $7.92K 10-Q · filed 2019-08-09 | ||
| 2019-03-31 | -$3.61K 10-Q · filed 2020-05-08 | |||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |